In a historic year for Kauffman Fellows, and the capital formation industry at large, the 2-year fellowship program welcomes 64 exceptionally diverse and highly talented leaders into Class 23. Selected from the most competitive and outstanding pool of applicants in the history of the organization, Class 23 is representative of the trending growth in the […]

A couple of star scientists at UPenn just got financial backing from AbbVie and other investors to come at solid tumors in an unusual way: re-engineering macrophages to eat up cancer cells. The Philadelphia-based company was first christened “Carma Therapeutics” when it launched last year, but thanks to pesky trademark conflicts its stepping out today […]

(Reuters) – Britain’s Orchard Therapeutics, which has already raised more than $140 million to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of GlaxoSmithKline (GSK.L) rare disease medicines. Chief Executive Mark Rothera also told Reuters that an initial public offering (IPO) was an option beyond […]